Cargando…
Nebivolol in the treatment of chronic heart failure
Nebivolol is a highly selective beta(1)-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to vasodilation and decreased peripheral vascular resistance. It is marketed in Europe for the treatment of hypertension and heart failure and i...
Autores principales: | Veverka, Angie, L Salinas, Jennifer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291309/ https://www.ncbi.nlm.nih.gov/pubmed/18078016 |
Ejemplares similares
-
Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure
por: Del Sindaco, Donatella, et al.
Publicado: (2010) -
Nebivolol therapy improves QTc and QTcd parameters in heart failure patients
por: Aksoy, SM, et al.
Publicado: (2012) -
Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure
with Normal Ejection Fraction
por: Messias, Leandro Rocha, et al.
Publicado: (2016) -
Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure
por: Karabacak, Mustafa, et al.
Publicado: (2015) -
Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)